DYNLL1
Dynein light chain 1, cytoplasmic
Also known as: DLC1, DLC8, DNCL1, DYL1_HUMAN, hdlc1, LC8, PIN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P63167
- Gene
- DYNLL1
- Ensembl
- ENSG00000088986
- Chromosome
- 12
- Canonical length
- 89 aa
- Protein class
- Cancer-related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol,Mid piece,Principal piece
- Quaternary structure
- Homodimer
OverviewNCBI Gene
Cytoplasmic dyneins are large enzyme complexes with a molecular mass of about 1,200 kD. They contain two force-producing heads formed primarily from dynein heavy chains, and stalks linking the heads to a basal domain, which contains a varying number of accessory intermediate chains. The complex is involved in intracellular transport and motility. The protein described in this record is a light chain and exists as part of this complex but also physically interacts with and inhibits the activity of neuronal nitric oxide synthase. Binding of this protein destabilizes the neuronal nitric oxide synthase dimer, a conformation necessary for activity, and it may regulate numerous biologic processes through its effects on nitric oxide synthase activity. Alternate transcriptional splice variants have been characterized. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
89 residues, UniProt reviewed canonical sequence.
>P63167|DYNLL1
1 MCDRKAVIKN ADMSEEMQQD SVECATQALE KYNIEKDIAA HIKKEFDKKY NPTWHCIVGR
61 NFGSYVTHET KHFIYFYLGQ VAILLFKSGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DYNLL1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 998 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 998 nTPM
- amygdala: 888 nTPM
- hippocampal formation: 875 nTPM
- esophagus: 769 nTPM
- hypothalamus: 758 nTPM
- spinal cord: 744 nTPM
Single-cell type
- esophageal apical cells: 9,920 nCPM
- late spermatids: 6,544 nCPM
- esophageal suprabasal cells: 5,019 nCPM
- fallopian tube ciliated cells: 2,437 nCPM
- respiratory ciliated cells: 2,308 nCPM
- suprabasal keratinocytes: 2,021 nCPM
Immune cell
- basophil: 519 nTPM
- plasmacytoid DC: 463 nTPM
- eosinophil: 386 nTPM
- T-reg: 375 nTPM
- total PBMC: 353 nTPM
- non-classical monocyte: 337 nTPM
Brain region
- white matter: 554 nTPM
- cerebral cortex: 508 nTPM
- basal ganglia: 490 nTPM
- hippocampal formation: 476 nTPM
- hypothalamus: 456 nTPM
- spinal cord: 432 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DYNLL1.
Disease | ImmuneIEDB
Conditions an epitope on DYNLL1 was assayed in.
- onchocerciasis B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.76
- gnomAD pLI
- 0.7
- gnomAD missense Z
- 2.01
- DepMap mean gene effect
- -0.56
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic process
- DNA damage response
- intraciliary retrograde transport
- motile cilium assembly
- negative regulation of nitric oxide biosynthetic process
- negative regulation of phosphorylation
- positive regulation of insulin secretion involved in cellular response to glucose stimulus
- positive regulation of intracellular transport
- spermatid development
- substantia nigra development
- negative regulation of DNA strand resection involved in replication fork processing
Molecular functions
- dynein intermediate chain binding
- enzyme binding
- enzyme inhibitor activity
- identical protein binding
- nitric-oxide synthase inhibitor activity
- protein-containing complex binding
- scaffold protein binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DYNLL1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DYNLL1 as an antibody target. Whether an autoantibody or antibody against DYNLL1 could matter depends on whether native DYNLL1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DYNLL1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DYNLL1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...